Trexquant Investment LP - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q4 2020$305,000
-4.4%
10,588
+4.3%
0.03%
+39.1%
Q1 2020$319,00010,1560.02%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q1 2021
NameSharesValueWeighting ↓
TRV GP, LLC 3,034,083$37,259,00042.17%
Svennilson Peter 4,677,939$57,446,00016.42%
VHCP Management II, LLC 726,677$8,924,0002.81%
Casdin Capital, LLC 1,523,960$18,714,229,0001.75%
P.A.W. CAPITAL CORP 120,000$1,474,0001.59%
Cormorant Asset Management, LP 1,271,685$15,616,0000.90%
VHCP Management III, LLC 66,667$819,0000.38%
Orbimed Advisors 835,842$10,264,0000.16%
Hillhouse Capital Management 317,921$3,904,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 183,600$2,255,0000.08%
View complete list of CONSTELLATION PHARMCETICLS I shareholders